Z. Zheng et al., Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk, J NAT CANC, 93(18), 2001, pp. 1411-1418
Background: UDP-glucuronosyltransferase 1A7 (UGT1A7) detoxifies several tob
acco carcinogens. We determined whether UGT1A7 expression is observed in no
rmal orolaryngeal tissue and whether UGT1A7 allelic variations are associat
ed with the risk for orolaryngeal cancer. Methods: UGT1A7 expression in nor
mal orolaryngeal tissue was determined by semiquantitative reverse transcri
ption-polymerase chain reaction (PCR). Buccal cell DNA isolated from 194 ca
se subjects with orolaryngeal cancer and from 388 control subjects who were
matched by sex, age, and race was subjected to UGT1A7 genotyping with the
use of combined PCR-restriction fragment length polymorphism and allelic di
scrimination analysis. All statistical tests were two-sided. Results: UGT1A
7 messenger RNA was expressed at similar levels in the esophagus, tongue, t
onsil, floor of the mouth, and larynx. Genotyping revealed the presence of
three variant reduced-activity UGT1A7 alleles in both Caucasians and Africa
n-Americans. Individuals with any of the predicted low-activity UGT1A7 geno
types had an increased risk of orolaryngeal cancer (odds ratio [OR] = 3.7;
95% confidence interval [CI] = 1.7 to 8.7) relative to subjects with the wi
ld-type genotype. Both Caucasians and African-Americans with the low-activi
ty genotypes had statistically significantly increased orolaryngeal cancer
risk compared with Caucasians and African-Americans with the wild-type geno
type (OR = 2.8 [95% CI = 1.1 to 7.6] and OR = 6.2 [95% CI = 1.2 to 31], res
pectively). For subjects with the predicted low-activity genotypes, the ris
ks of oral cavity cancer (OR = 4.2; 95% CI = 1.7 to 10) and laryngeal cance
r (OR = 3.7; 95% CI = 0.99 to 14) were similar. There was no association be
tween UGT1A7 genotype and orolaryngeal cancer risk in never smokers, wherea
s subjects with predicted low-activity UGT1A7 genotypes who were light smok
ers (OR = 3.7; 95% CI = 1.1 to 12) or heavy smokers (OR = 6.1; 95% CI:= 1.5
to 25) had an increased risk. Conclusions: The tissue expression of UGT1A7
is consistent with the possibility of a physiologic role in orolaryngeal c
ancer. Variations in the UGT1A7 gene that reduce UGT1A7 activity may affect
the risk of smoking-related orolaryngeal cancer.